Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TMEM176A inhibitors(transmembrane protein 176A inhibitors), TMEM176B inhibitors(transmembrane protein 176B inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | AR | ![]() | 01 Dec 2024 |